Challenges and new technologies in adoptive cell therapy

Adoptive cell therapies (ACTs) have existed for decades. From the initial infusion of tumor-infiltrating lymphocytes to the subsequent specific enhanced T cell receptor (TCR)-T and chimeric antigen receptor (CAR)-T cell therapies, many novel strategies for cancer treatment have been developed. Owing...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Pengchao, Zhang, Guizhong, Wan, Xiaochun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10439661/
https://www.ncbi.nlm.nih.gov/pubmed/37596653
http://dx.doi.org/10.1186/s13045-023-01492-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10439661/
https://www.ncbi.nlm.nih.gov/pubmed/37596653
http://dx.doi.org/10.1186/s13045-023-01492-8

Ejemplares similares